Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer. [electronic resource]
Producer: 20150320Description: 313-8 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- genetics
- Cell Line, Tumor
- Cetuximab
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Resistance, Neoplasm
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Molecular Targeted Therapy
- Panitumumab
- Telomere
- Telomere Shortening
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.